Abstract

We succeeded in simultaneously synthesizing the vitamin D family, vitamins D2, D4, D5, D6, and D7, from β-sitosterol, which is sold as a commercially available reagent from Tokyo Chemical Industry Co., Ltd. It is officially sold as a mixture of four phytosterols {β-sitosterol (40–45%), campesterol (20–30%), stigmasterol, and brassicasterol}. Owing to this, we anticipated that, using this reagent, various vitamin D analogs could be synthesized simultaneously. We also synthesized vitamin D3 from pure cholesterol and analyzed and compared all vitamin D analogs (D2, D3, D4, D5, D6, and D7) by HSQC NMR. We succeeded in clearly demonstrating the difference in the NMR chemical shifts for each vitamin D analog.

Highlights

  • Introduction{(5Z,7E)-(3S)-9,10-seco-5,7,10(19)-stigmastatrien-3-ol}, D6 {(22E)-(24R)-ethyl-22,23- didehydrocalciol or (5Z,7E,22E)-(3S)-9,10-seco-5,7,10(19),22-stigmastatetraen-3-ol}, and D7 {(5Z,7E,24R)-(3S)-9,10seco-5,7,10(19)-ergostatrien-3-ol} and contributes to important biological functions after converting to active forms [2]

  • The vitamin D family [1] is known as vitamins D2 {ergocalciferol or (5Z,7E,22E)-(3S)-9,10-seco5,7,10(19),22-ergostatetraen-3-ol}, D3 {cholecalciferol or (5Z,7E)-(3S)-9,10-seco-5,7,10(19)cholestatrien-3-ol}, D4 {22,23-dihydroercalciol or (5Z,7E)-(3S)-9,10-seco-5,7,10(19)-ergostatrien-3-ol), D5{(5Z,7E)-(3S)-9,10-seco-5,7,10(19)-stigmastatrien-3-ol}, D6 {(22E)-(24R)-ethyl-22,23- didehydrocalciol or (5Z,7E,22E)-(3S)-9,10-seco-5,7,10(19),22-stigmastatetraen-3-ol}, and D7 {(5Z,7E,24R)-(3S)-9,10seco-5,7,10(19)-ergostatrien-3-ol} and contributes to important biological functions after converting to active forms [2]

  • Focusing on commercially available β-sitosterol (Figure 1, Compound 1), it contains campesterol and stigmasterol and brassicasterol according to the manufacturer; we anticipated that four types of vitamin D could be synthesized simultaneously

Read more

Summary

Introduction

{(5Z,7E)-(3S)-9,10-seco-5,7,10(19)-stigmastatrien-3-ol}, D6 {(22E)-(24R)-ethyl-22,23- didehydrocalciol or (5Z,7E,22E)-(3S)-9,10-seco-5,7,10(19),22-stigmastatetraen-3-ol}, and D7 {(5Z,7E,24R)-(3S)-9,10seco-5,7,10(19)-ergostatrien-3-ol} and contributes to important biological functions after converting to active forms [2]. These vitamin D analogs differ only in the structure of their side chains, they have different activities in vivo. Active forms of vitamin D3 are used as anti-osteoporosis drugs, but hypercalcemia due to excessive intake has been reported as a side effect. It is very important to compare each vitamin D to examine its functions. Methods for obtaining each vitamin D analog simultaneously have not yet been developed. The characteristic peaks of each vitamin D analog (vitamins D2 , D3 , D4 , D5 , D6 , and D7 ) were examined by comparative analysis

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call